Literature DB >> 4124041

Epstein-Barr-virus antibodies in American and African Burkitt's lymphoma.

Y Hirshaut, M H Cohen, D A Stevens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4124041     DOI： 10.1016/s0140-6736(73)93061-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Surface marker characteristics and Epstein-Barr virus studies of two established North American Burkitt's lymphoma cell lines.

Authors:  A L Epstein; W Henle; G Henle; J F Hewetson; H S Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

Review 2.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1974-08       Impact factor: 2.401

3.  Letter: E.B. virus and treatment of lymphomas.

Authors:  G De-Thé; A Geser; E H Williams
Journal:  Br Med J       Date:  1974-11-23

Review 4.  [Burkitt-like lymphoma: diagnosis, clinical features, and response to chemotherapy (author's transl)].

Authors:  U Jehn; A Wohlrab; W Wilmanns
Journal:  Klin Wochenschr       Date:  1979-10-15

5.  Neoplasms, differentiations and mutations.

Authors:  G B Pierce
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

Review 6.  Are viruses important in carcinogenesis?

Authors:  F Rapp; E R Buss
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

7.  EB virus and the treatment of lymphomas.

Authors:  R Salm
Journal:  Br Med J       Date:  1974-05-25

Review 8.  Commentary. EB virus, infectious mononucleosis, and cancer: the closing of the web.

Authors:  A S Evans
Journal:  Yale J Biol Med       Date:  1974

9.  Burkitt-type lymphoma in France among non-Hodgkin malignant lymphomas in Caucasian children.

Authors:  T Philip; G M Lenoir; P A Bryon; R Gerard-Marchant; G Souillet; N Philippe; F Freycon; M Brunat-Mentigny
Journal:  Br J Cancer       Date:  1982-05       Impact factor: 7.640

10.  Mutations in the IGF-II pathway that confer resistance to lytic reovirus infection.

Authors:  Jinsong Sheng; Edward L Organ; Chuanming Hao; K Sam Wells; H Earl Ruley; Donald H Rubin
Journal:  BMC Cell Biol       Date:  2004-08-27       Impact factor: 4.241
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.